波音游戏-波音娱乐城赌球打不开

Mapping a biotech future in Hong Kong

Regina Lau

 

Recent biotech achievements in China offer immense opportunities for Hong Kong to enhance her position in biotechnology, one of the most promising industries for coming decades, said Professor Y L Lo, Founding Chairman of the Hong Kong Biotechnology Association, at CityU on 20 January. Professor Lo's lecture, "Biotechnology-the Catalyst of Hong Kong's Future Economic Development?" was the latest in the Distinguished Industrialist Lecture Series, organized by CityU's Faculty of Science and Engineering to foster closer links between the University community and the business sector. "Collaborating with China and participation in i

nternational biotech projects are crucial steps for Hong Kong to establish itself in this mega trend for the 21st century," he told the audience.

Professor Lo, who is also the President (Asia Pacific) of PerkinElmer Life and Sciences (Hong Kong) Limited, a US based biotech company, gave a comprehensive picture of biotech development in the Asia Pacific region, which is set to become the engine for global economic growth. Governments in Taiwan, Korea, Singapore and Japan have shown a clear commitment to expanding the biotech industry, which has also experienced booming investment from the private sector. With her growing contributions to the Human Genome Project, breakthroughs in decoding the hybrid rice genome, and production of recombinant drugs and vaccines, China is capable of becoming a future leader in the Asia biotech industry, he said.

"In Hong Kong, the biotech industry is currently very much trade-based. We are lagging behind our neighbors in terms of technological innovation and R&D investment," said Professor Lo. "But with a strong service base, heightened awareness among our entrepreneurs of the huge potential of the life science industry, and our position as China's bridge to the world, Hong Kong is well situated to find a niche in the booming biotech field."

The process of commercialization and technology transfer in biotechnology creates huge opportunities for various sectors, including the legal and fina

nce sectors. Instead of starting from scratch, Hong Kong should focus on the advanced stages of the process, Professor Lo said. "Immense opportunities in servicing and intellectual property protection at the advanced stage of the process are waiting to be explored." 

 

YOU MAY BE INTERESTED

Contact Information

Communications and Institutional Research Office

Back to top
定襄县| 大发888赌博网站| 娱乐城百家乐怎么样| 百家乐投住系统| 汉百家乐春| 大发888案件| 奇博娱乐| 罗马百家乐官网娱乐城| 百家乐官网赌博游戏平台| 三星百家乐官网的玩法技巧和规则 | 威尼斯人娱乐城网上赌博| 棋牌娱乐城注册送58| 百胜百家乐官网软件| 全讯网.com| 百家乐注册平台排名| 金木棉百家乐的玩法技巧和规则| 大发888提款之后多久到账| 皇冠网上投注站| 真人百家乐官网娱乐场| 网上百家乐官网赌| 百家乐现金投注信誉平台| 为什么百家乐玩家越来越多选择网上百家乐 | 成都百家乐官网的玩法技巧和规则 | 利博百家乐破解| 百家乐官网开庄几率| 百家乐官网网上真钱娱乐| 百家乐斗地主在哪玩| 百家乐博弈指| 皇家国际娱乐| 百家乐官网游戏玩法技巧| 91百家乐官网的玩法技巧和规则| 百家乐官网路珠价格| 百家乐技巧和规律| 巴厘岛百家乐官网的玩法技巧和规则 | 网上百家乐官网做假| 百家乐官网揽法大全| 百家乐高额投注| 威尼斯人娱乐城怎么样lm0| 大发888手机版下载安| 大发888官网注册| 太阳城百家乐官网168|